Update on RAF resistance in metastatic melanoma

The state of play in overcoming resistance to RAF inhibition in metastatic melanoma - where do we go next?

January 31, 2014

Developing a predictive biomarker for PARP inhibition

Is CDK12 deficiency a clinically relevant predictive biomarker of PARP1/2 inhibitor sensitivity?

February 7, 2014

Removing the PD-1 brake enhances the effect on adoptive CAR T cells

CAR T cells and PD-1 antibodies are two of the hottest topics in immunotherapy right now, but what would happen if you combined them?

October 16, 2013